Pfizer invests $120M in 4 biotechs through new growth fund

Pfizer has made the first investments through its $500 million Pfizer Breakthrough Growth Initiative (PBGI). Homology Medicines received the biggest piece of the first tranche of PBGI funding, landing $60 million to support its work on treatments for rare genetic diseases.